Advanced Pathophysiology for the Advanced Practice Nurse
Sue Butz DNP RN CCRN-K and John Chovan PhD DNP RN APRN-CNP APRN-CNS
Hypercoagulable, Coronavirus, COVID-19, Blood Clot, Pathophysiology, SARS-CoV-2
Family Practice Nursing | Medicine and Health Sciences | Nursing
From the data that has been collected and compiled on SARS-CoV-2, or Coronavirus disease 2019 (COVID-19), it has shown that there are unique qualities of the novel virus that leads to a hypercoagulable state in those diagnosed. To effectively treat those afflicted with this specific symptom of COVID-19, an understanding of the pathophysiology of the virus must be established to effectively treat and potentially prevent coagulopathy and the thrombotic events that can ensue. Gaining more insight into this will allow for standardized plan of care that includes appropriate predicative labs and effective prophylactic medications to be utilized in outpatient or inpatient settings to prevent a hypercoagulable state from occurring or minimize the mortality risk of these patients.
Copyright, all rights reserved. Fair Use
Martin, Amanda, "Hypercoagulable State of COVID-19" (2021). Nursing Student Class Projects (Formerly MSN). 488.